Clear and open communication
A vital aspect of our commitment to patient safety is making sure that accurate and up-to-date information is provided to support effective use of our medicines.
During the new medicine approval process, we work with regulators to develop prescribing information that provides healthcare professionals with the benefit/risk information they need to make appropriate prescribing decisions. This information includes indications for use, dosing recommendations, warnings and contra-indications, as well as what side effects might be experienced.
We also make information available directly to patients, as appropriate, about our medicines and how they should be taken.
We continue to provide information throughout a medicine’s life, including any new safety data that becomes available through our continuous monitoring processes.